Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S.M. Thirdborough

Transcriptional Networks Associated With Treatment Failure in Advanced-Stage Hodgkin Lymphoma: Data From the Rathl Trial (Cruk/07/033)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cd27 Stimulation Enhances Cd20 Mab Therapy Through Activation of Innate Immunity

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Related publications

PET-guided Treatment in Advanced-Stage Hodgkin Lymphoma: Yes but Which One?

Oncotarget
Oncology
2019English

Interleukin-10 Gene Polymorphisms Are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2013English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

Human Germinal Center-Associated Lymphoma Protein Expression Is Associated With Improved Failure-Free Survival in Brazilian Patients With Classical Hodgkin Lymphoma

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2009English

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Cost-Effectiveness and Cost-Utility Analysis of Multiple Treatment Strategies Using Abvd and/or Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Clinical Outcomes Associated With the Treatment of Newly Diagnosed Stage Iv Classical Hodgkin Lymphoma in Practice Settings in France, Germany and the United Kingdom

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Examining Rare Side Effects in Pooled Trial Data: Symptomatic Osteonecrosis in Hodgkin Lymphoma

Oncotarget
Oncology
2018English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy